Shares of Sequenom Inc. (Nasdaq: SQNM) collapsed $11.27 to $3.64 after the company delayed the launch of its Down syndrome test.
Sequenom Delays Launch Of Down Syndrome Test
April 30, 2009 at 13:42 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.